$ASPX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Auspex Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Auspex Pharmaceuticals, Inc.. Get notifications about new insider transactions in Auspex Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Sell | U | 0.00 | 973,379 | 0 | 0 | 973.4 K to 0 (-100.00 %) |
May 07 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Sell | U | 0.00 | 849,426 | 0 | 0 | 849.4 K to 0 (-100.00 %) |
May 07 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Sell | U | 0.00 | 1,182,943 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
May 07 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Sell | U | 0.00 | 953,286 | 0 | 0 | 953.3 K to 0 (-100.00 %) |
May 07 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Sell | U | 0.00 | 490,069 | 0 | 0 | 490.1 K to 0 (-100.00 %) |
May 07 2015 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Sell | U | 0.00 | 4,835,731 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | GREER R SCOTT | Director | Option Exercise | D | 18.13 | 20,000 | 362,600 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | GREER R SCOTT | Director | Sell | U | 0.00 | 7,190 | 0 | 0 | 7.2 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Sarshar Sepehr | Director | Sell | U | 0.00 | 242,574 | 0 | 0 | 242.6 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | FERGUSON RODNEY A | Director | Sell | U | 0.00 | 2,500,589 | 0 | 0 | 2.5 M to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | SCHNEIDER PHILLIP M | Director | Option Exercise | D | 18.13 | 6,667 | 120,873 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | SCHNEIDER PHILLIP M | Director | Option Exercise | D | 12.00 | 13,333 | 159,996 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | PROEHL GERALD T | Director | Option Exercise | D | 18.13 | 6,667 | 120,873 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | PROEHL GERALD T | Director | Option Exercise | D | 6.57 | 13,333 | 87,598 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | PROEHL GERALD T | Director | Sell | U | 0.00 | 1,466 | 0 | 0 | 1.5 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Bleil Lynn Dorsey | Director | Option Exercise | D | 18.13 | 20,000 | 362,600 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Option Exercise | D | 0.00 | 15,000 | 0 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Option Exercise | D | 59.66 | 30,000 | 1,789,800 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Option Exercise | D | 0.86 | 27,235 | 23,422 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Option Exercise | D | 0.86 | 47,777 | 41,088 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Option Exercise | D | 0.90 | 7,777 | 6,999 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Sell | U | 0.00 | 67,338 | 0 | 0 | 67.3 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | CHOWRIRA BHARAT M | Chief Operating Off ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | CHOWRIRA BHARAT M | Chief Operating Off ... | Option Exercise | D | 59.66 | 40,000 | 2,386,400 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | CHOWRIRA BHARAT M | Chief Operating Off ... | Option Exercise | D | 0.54 | 297,777 | 160,800 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | CHOWRIRA BHARAT M | Chief Operating Off ... | Sell | U | 0.00 | 8,297 | 0 | 0 | 8.3 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | D | 59.66 | 60,000 | 3,579,600 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | D | 0.54 | 26,219 | 14,158 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | D | 0.86 | 66,666 | 57,333 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | D | 0.90 | 20,623 | 18,561 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | D | 0.90 | 25,274 | 22,747 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Sell | U | 0.00 | 1,627 | 0 | 0 | 1.6 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Schmid John P. | Chief Financial Off ... | Option Exercise | D | 0.00 | 15,000 | 0 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Schmid John P. | Chief Financial Off ... | Option Exercise | D | 59.66 | 30,000 | 1,789,800 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Schmid John P. | Chief Financial Off ... | Option Exercise | D | 6.57 | 59,026 | 387,801 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Schmid John P. | Chief Financial Off ... | Sell | U | 0.00 | 144,444 | 0 | 0 | 144.4 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Shah Pratik | President and CEO | Option Exercise | D | 0.00 | 100,000 | 0 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Shah Pratik | President and CEO | Option Exercise | D | 59.66 | 200,000 | 11,932,000 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Shah Pratik | President and CEO | Option Exercise | D | 6.57 | 215,153 | 1,413,555 | 0 | |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Shah Pratik | President and CEO | Sell | U | 0.00 | 903,018 | 0 | 0 | 903 K to 0 (-100.00 %) |
May 06 2015 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Sell | U | 0.00 | 4,835,731 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
Apr 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | J | 17.65 | 1 | 18 | 0 | |
Apr 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 29.79 | 1 | 30 | 0 | |
Apr 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | J | 17.65 | 1 | 18 | 0 | |
Apr 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 29.79 | 1 | 30 | 0 | |
Apr 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | X | 29.79 | 7,500 | 223,425 | 63,589 | 71.1 K to 63.6 K (-10.55 %) |
Apr 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | X | 29.79 | 292,500 | 8,713,575 | 2,478,021 | 2.8 M to 2.5 M (-10.56 %) |
Mar 17 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | M | 0.90 | 3,000 | 2,700 | 25,274 | |
Mar 17 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Sell | S | 80.08 | 2,600 | 208,195 | 983 | 3.6 K to 983 (-72.56 %) |
Mar 17 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Sell | S | 79.55 | 400 | 31,820 | 3,583 | 4 K to 3.6 K (-10.04 %) |
Mar 17 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Buy | M | 0.90 | 3,000 | 2,700 | 3,983 | 983 to 4 K (+305.19 %) |
Feb 26 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | J | 0.00 | 5,000 | 0 | 71,089 | 76.1 K to 71.1 K (-6.57 %) |
Feb 26 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | J | 0.00 | 195,000 | 0 | 2,770,521 | 3 M to 2.8 M (-6.58 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 62.98 | 1,047 | 65,943 | 76,089 | 77.1 K to 76.1 K (-1.36 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 64.00 | 325 | 20,800 | 77,136 | 77.5 K to 77.1 K (-0.42 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 62.96 | 1,696 | 106,782 | 77,461 | 79.2 K to 77.5 K (-2.14 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 62.98 | 40,786 | 2,568,825 | 2,965,521 | 3 M to 3 M (-1.36 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 64.00 | 12,675 | 811,200 | 3,006,307 | 3 M to 3 M (-0.42 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 62.96 | 66,138 | 4,164,128 | 3,018,982 | 3.1 M to 3 M (-2.14 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 3.88 | 1,058 | 4,104 | 0 | |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 3.88 | 41,282 | 160,133 | 0 | |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 49.13 | 84 | 4,127 | 83,589 | 83.7 K to 83.6 K (-0.10 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | X | 3.88 | 1,058 | 4,104 | 83,673 | 82.6 K to 83.7 K (+1.28 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 49.13 | 3,260 | 160,161 | 3,258,021 | 3.3 M to 3.3 M (-0.10 %) |
Feb 17 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | X | 3.88 | 41,282 | 160,133 | 3,261,281 | 3.2 M to 3.3 M (+1.28 %) |
Feb 11 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 61.84 | 1,327 | 82,062 | 79,157 | 80.5 K to 79.2 K (-1.65 %) |
Feb 11 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 60.05 | 530 | 31,827 | 80,484 | 81 K to 80.5 K (-0.65 %) |
Feb 11 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.00 | 246 | 14,514 | 81,014 | 81.3 K to 81 K (-0.30 %) |
Feb 11 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 61.84 | 51,773 | 3,201,642 | 3,112,120 | 3.2 M to 3.1 M (-1.64 %) |
Feb 11 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 60.05 | 20,670 | 1,241,234 | 3,163,893 | 3.2 M to 3.2 M (-0.65 %) |
Feb 11 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.00 | 9,608 | 566,872 | 3,157,563 | 3.2 M to 3.2 M (-0.30 %) |
Feb 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.48 | 757 | 45,026 | 81,260 | 82 K to 81.3 K (-0.92 %) |
Feb 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.51 | 322 | 19,162 | 82,017 | 82.3 K to 82 K (-0.39 %) |
Feb 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.30 | 1,250 | 74,125 | 82,339 | 83.6 K to 82.3 K (-1.50 %) |
Feb 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.48 | 29,522 | 1,755,969 | 3,167,171 | 3.2 M to 3.2 M (-0.92 %) |
Feb 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.51 | 12,578 | 748,517 | 3,196,693 | 3.2 M to 3.2 M (-0.39 %) |
Feb 06 2015 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 59.30 | 48,750 | 2,890,875 | 3,209,271 | 3.3 M to 3.2 M (-1.50 %) |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | A | 59.66 | 60,000 | 3,579,600 | 60,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Shah Pratik | President and CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Shah Pratik | President and CEO | Option Exercise | A | 59.66 | 200,000 | 11,932,000 | 200,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Schmid John P. | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Schmid John P. | Chief Financial Off ... | Option Exercise | A | 59.66 | 30,000 | 1,789,800 | 30,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | Saks Samuel R | Chief Development O ... | Option Exercise | A | 59.66 | 30,000 | 1,789,800 | 30,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | CHOWRIRA BHARAT M | Chief Operating Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Feb 04 2015 | ASPX | Auspex Pharmaceuti ... | CHOWRIRA BHARAT M | Chief Operating Off ... | Option Exercise | A | 59.66 | 40,000 | 2,386,400 | 40,000 | |
Jan 30 2015 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Sell | S | 53.11 | 730,000 | 38,770,300 | 4,835,731 | 5.6 M to 4.8 M (-13.12 %) |
Jan 30 2015 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Sell | S | 53.11 | 730,000 | 38,770,300 | 4,835,731 | 5.6 M to 4.8 M (-13.12 %) |
Jan 28 2015 | ASPX | Auspex Pharmaceuti ... | Panorama Capital, L.P. | 10% Owner | Sell | S | 53.11 | 270,000 | 14,339,700 | 2,500,589 | 2.8 M to 2.5 M (-9.75 %) |
Jan 28 2015 | ASPX | Auspex Pharmaceuti ... | FERGUSON RODNEY A | Director | Sell | S | 53.11 | 270,000 | 14,339,700 | 2,500,589 | 2.8 M to 2.5 M (-9.75 %) |
Jan 28 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 56.50 | 192,240 | 10,861,560 | 973,379 | 781.1 K to 973.4 K (+24.61 %) |
Jan 28 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 56.50 | 167,760 | 9,478,440 | 849,426 | 681.7 K to 849.4 K (+24.61 %) |
Jan 28 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 56.50 | 566,825 | 32,025,613 | 1,182,943 | 616.1 K to 1.2 M (+92.00 %) |
Jan 28 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 56.50 | 458,175 | 25,886,888 | 953,286 | 495.1 K to 953.3 K (+92.54 %) |
Jan 28 2015 | ASPX | Auspex Pharmaceuti ... | Flynn James E | 10% Owner | Buy | P | 56.50 | 115,000 | 6,497,500 | 490,069 | 375.1 K to 490.1 K (+30.66 %) |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | M | 3.88 | 90,228 | 349,994 | 0 | |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | M | 3.88 | 169,630 | 657,995 | 0 | |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | M | 3.88 | 59,277 | 229,935 | 0 | |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Sell | D | 51.57 | 24,008 | 1,238,189 | 5,565,731 | 5.6 M to 5.6 M (-0.43 %) |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Buy | M | 3.88 | 319,135 | 1,237,925 | 5,589,739 | 5.3 M to 5.6 M (+6.05 %) |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | M | 3.88 | 90,228 | 349,994 | 0 | |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | M | 3.88 | 169,630 | 657,995 | 0 | |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | M | 3.88 | 59,277 | 229,935 | 0 | |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Sell | D | 51.57 | 24,008 | 1,238,189 | 5,565,731 | 5.6 M to 5.6 M (-0.43 %) |
Jan 12 2015 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Buy | M | 3.88 | 319,135 | 1,237,925 | 5,589,739 | 5.3 M to 5.6 M (+6.05 %) |
Dec 23 2014 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Option Exercise | M | 0.90 | 2,660 | 2,394 | 28,274 | |
Dec 23 2014 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Sell | S | 53.92 | 1,100 | 59,316 | 983 | 2.1 K to 983 (-52.81 %) |
Dec 23 2014 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Sell | S | 53.28 | 1,560 | 83,118 | 2,083 | 3.6 K to 2.1 K (-42.82 %) |
Dec 23 2014 | ASPX | Auspex Pharmaceuti ... | Stamler David A | Chief Medical Offic ... | Buy | M | 0.90 | 2,660 | 2,394 | 3,643 | 983 to 3.6 K (+270.60 %) |
Dec 22 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | J | 0.00 | 7,625 | 0 | 82,615 | 90.2 K to 82.6 K (-8.45 %) |
Dec 22 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | J | 0.00 | 297,375 | 0 | 3,219,999 | 3.5 M to 3.2 M (-8.45 %) |
Dec 22 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 50.14 | 4,875 | 244,433 | 90,240 | 95.1 K to 90.2 K (-5.13 %) |
Dec 22 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 50.14 | 190,125 | 9,532,868 | 3,517,374 | 3.7 M to 3.5 M (-5.13 %) |
Nov 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | S | 0.00 | 1 | 0 | 1 | |
Nov 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | P | 0.00 | 1 | 0 | 1 | |
Nov 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | S | 0.00 | 1 | 0 | 1 | |
Nov 12 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | P | 0.00 | 1 | 0 | 1 | |
Oct 31 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.33 | 197 | 5,383 | 95,115 | 95.3 K to 95.1 K (-0.21 %) |
Oct 31 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.33 | 7,633 | 208,582 | 3,707,499 | 3.7 M to 3.7 M (-0.21 %) |
Oct 31 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.02 | 279 | 7,539 | 95,312 | 95.6 K to 95.3 K (-0.29 %) |
Oct 31 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.02 | 10,891 | 294,307 | 3,715,132 | 3.7 M to 3.7 M (-0.29 %) |
Oct 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 26.99 | 275 | 7,422 | 95,591 | 95.9 K to 95.6 K (-0.29 %) |
Oct 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 26.99 | 10,725 | 289,476 | 3,726,023 | 3.7 M to 3.7 M (-0.29 %) |
Oct 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.11 | 87 | 2,359 | 95,866 | 96 K to 95.9 K (-0.09 %) |
Oct 29 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.11 | 3,413 | 92,541 | 3,736,748 | 3.7 M to 3.7 M (-0.09 %) |
Oct 27 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.09 | 272 | 7,367 | 95,953 | 96.2 K to 96 K (-0.28 %) |
Oct 27 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 27.09 | 10,628 | 287,866 | 3,740,161 | 3.8 M to 3.7 M (-0.28 %) |
Oct 27 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 26.74 | 140 | 3,743 | 96,225 | 96.4 K to 96.2 K (-0.15 %) |
Oct 27 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 26.74 | 5,460 | 145,974 | 3,750,789 | 3.8 M to 3.8 M (-0.15 %) |
Oct 14 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | M | 3.88 | 60,151 | 233,326 | 0 | |
Oct 14 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Sell | D | 23.89 | 9,771 | 233,380 | 5,270,604 | 5.3 M to 5.3 M (-0.19 %) |
Oct 14 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Buy | M | 3.88 | 60,151 | 233,326 | 5,280,375 | 5.2 M to 5.3 M (+1.15 %) |
Oct 14 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Option Exercise | M | 3.88 | 60,151 | 233,326 | 0 | |
Oct 14 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Sell | D | 23.89 | 9,771 | 233,380 | 5,270,604 | 5.3 M to 5.3 M (-0.19 %) |
Oct 14 2014 | ASPX | Auspex Pharmaceuti ... | Zisson Alex | Director | Buy | M | 3.88 | 60,151 | 233,326 | 5,280,375 | 5.2 M to 5.3 M (+1.15 %) |
Oct 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 3.88 | 1,074 | 4,166 | 0 | |
Oct 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Option Exercise | X | 3.88 | 41,892 | 162,499 | 0 | |
Oct 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.45 | 178 | 4,173 | 104,504 | 104.7 K to 104.5 K (-0.17 %) |
Oct 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | X | 3.88 | 1,074 | 4,166 | 104,682 | 103.6 K to 104.7 K (+1.04 %) |
Oct 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Sell | S | 23.45 | 6,931 | 162,497 | 3,781,210 | 3.8 M to 3.8 M (-0.18 %) |
Oct 08 2014 | ASPX | Auspex Pharmaceuti ... | CMEA Ventures VII LP | 10% Owner | Buy | X | 3.88 | 41,892 | 162,499 | 3,788,141 | 3.7 M to 3.8 M (+1.12 %) |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | M | 3.88 | 243 | 943 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | M | 3.88 | 64,918 | 251,817 | 0 | |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Sell | D | 20.60 | 46 | 948 | 19,313 | 19.4 K to 19.3 K (-0.24 %) |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Sell | D | 20.60 | 12,226 | 251,831 | 5,147,143 | 5.2 M to 5.1 M (-0.24 %) |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Buy | M | 3.88 | 243 | 943 | 19,359 | 19.1 K to 19.4 K (+1.27 %) |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Buy | M | 3.88 | 64,918 | 251,817 | 5,159,369 | 5.1 M to 5.2 M (+1.27 %) |
Oct 01 2014 | ASPX | Auspex Pharmaceuti ... | Thomas, McNerney & Partners II ... | Director | Option Exercise | C | 3.88 | 89,299 | 346,391 | 89,299 |